POLD1 and Marinesco-Sjogren syndrome: This review synthesizes recent advances in understanding how POLD1 mutations orchestrate both tumorigenesis and immunotherapy responses, proposing a central hypothesis: POLD1 mutations redefine the therapeutic landscape of MSS tumors by reshaping their mutational landscape and immune microenvironment, independent of traditional MSI pathways.